Advanced Seminars in Behavioral Neuroendocrinology - Serotonergic Psychedelics
Summers
SN2ACKS: Systems and Neuroscience Networks Advanced Communication of Knowledge Seminars
Formerly: Advanced Seminars in Behavioral Neuroendocrinology

Serotonergic Psychedelics
Spring 2020
end
Date Speaker
streaming video
Title of the 1o Journal Paper Authors year,
journal
volume:
pages
food
Jan 17
UCL
173
Cliff
Scheduling

Building a Good Scientific Story

Full USD Syllabus for the Seminar course Serotonergic Psychedelics

CH Summers 2020
Jan 31
UCL
173
Kevin
Krupp
Introduction to Serotonergic Psychedelics
Classic psychedelics as therapeutics for psychiatric disorders


Background paper:
MW Johnson 2018 International Review of Psychiatry 30: 285–290 Psychiatry might need some psychedelic therapy

CD Nichols
PS Hendricks

2020,
Handbook
Behavioral
Neurobiology
of Serotonin
2nd Edition Chapter 49
https://doi.org/:
10.1016/
B978-0-444-64125-0.00049-9
Jaz
Feb 21
UCL
173
Kevin
Krupp




Cliff
Fully automated head-twitch detection system for the study of 5-HT2A receptor pharmacology in vivo

Background papers:
Berthoux, Barre, Bockaert, Marin, Bécamel 2019 Cerebral Cortexdoi: 10.1093/cercor/bhy064: 1-11 Sustained activation of postsynaptic 5-HT2A receptors gates plasticity at prefrontal cortex synapses



Martin and Nichols 2016 EBioMedicine 11: 262–277 Psychedelics recruit multiple cellular types and produce complex transcriptional responses within the brain



How to chose a paper, What makes a good talk, Guide to Seminar Design

SN2ACKS Seminar Success Guide

Organization of your Talk

M de la Fuente
Revenga
JM Shin
HZ Vohra
KS Hideshima
M Schneck
JL Poklis
J González-Maeso
2019
Scientific
Reports
9:
14247:
1-14
Riley
Feb 28
UCL
173
Ben
Onserio

The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension

Background papers:
Dakic et al., 2017 Scientific Reports 7: 12862: 1-13 Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT

Catlow, Jalloh, Sanchez-Ramos 2016 Neuropathology of Drug Addictions and Substance Misuse, Volume 2: 821–831 Hippocampal neurogenesis: Effects of psychedelic drugs. http://dx.doi.org/10.1016/B978-0-12-800212-4.00077

Z Marinova
S Walitza
E Gru¨nblatt
2017
J Neural
Transm
124:
749–759
Chinenye
Mar 6
UCL
190
Avery
Del Grosso
CaMello-XR enables visualization and optogenetic control of Gq/11 signals and receptor trafficking in GPCR-specific domains

Background papers:
Gao et al., 2018 Neuropharmacology 141: 167 – 180 Activation of 5-HT2A receptor disrupts rat maternal behavior

Gan, 2018 Brit J Anaesthesia 120: 818-826 5-Hydroxytryptamine 2A receptor inverse agonist pimavanserin impairs maternal behavior in postpartum female rats

H Zhou
Q Zhang
E Martinez
J Dale
S Hu
E Zhang
KLiu
D Huang
G Yang
Z Chen
J Wang

2018
Nature
Communications
9: 3751:
1–13
DOI: 10.1038/s41467-018-06295-x
Ben
Mar 27
UCL
173
Riley
Paulsen

Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway

Background papers:
Viñals et al., 2015 PLoS Biology 13(7): e1002194. doi:10.1371/journal.pbio.1002194 1–40 Cognitive impairment induced by Delta9-tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors

De Gregorio et al., 2019 Pain 160: 136–150 Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain

Ibarra-Lecue
I Mollinedo-Gajate
JJ Meana
LF Callado
R Diez-Alarcia
L Urigüen
2018
Neuropsycho-
pharmacology
5:
486-497
Naleeka
Apr 3
UCL
173
Chinenye
Izuegbunam

Psychedelics, but Not Ketamine, Produce Persistent antidepressant-like effects in a rodent experimental system for the study of depression

Background papers:
BD Sachs, JR Ni, MG Caron 2015 PNAS 112: 2557–2562 Brain 5-HT deficiency increases stress vulnerability and impairs antidepressant responses following psychosocial stress

M Angoa-Perez, MJ Kane, DI Briggs, N Herrera-Mundo, CE Sykes,M Francescutti, DM Kuhn 2014 ACS Chemical Neuroscience 5: 908–919 Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype
M Hibicke
AN Landry
HM Kramer
ZK Talman
CD Nichols
2020
ACS
Chemical
Neuroscience
11:
864-871
Jason
Apr 17
UCL
173
Jaz
Yaeger
Involvement of serotonin 2A receptor activation in modulating medial prefrontal cortex and amygdala neuronal activation during novelty-exposure
Background papers:
P Botta, A Fushiki, AM Vicente, LA Hammond, AC Mosberger, CR Gerfen, D Peterka, RM Costa 2019 PrePrint BioRxiv 1-47 An amygdala circuit mediates experience-dependent momentary exploratory arrests

E Hasegawa, T Maejima, T Yoshida, OA Masseck, S Herlitze, M Yoshioka, T Sakurai, M Mieda 2017 PNAS 114: E3526–E3535 Serotonin neurons in the dorsal raphe mediate the anticataplectic action of orexin neurons by reducing amygdala activity
ME-S Hervig
NCH Jensen
NB Rasmussen
R Rydbirk
MV Olesen
Anders Hay-Schmidt
B Pakkenberg
S Aznar
2017
Behavioral
Brain
Research
326:
1–12
Avery
Apr 24
UCL
173
Naleeka
Mohotti
Malwattage
The endogenous hallucinogen and trace amine N,N-dimethyltryptamine(DMT) displays potent protective effects against hypoxia via Sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells
Background papers:

Zhang 2017Neuropharmacology 116: 387e398 Sigma-1 receptor deficiency reduces GABAergic inhibition in the basolateral amygdala leading to LTD impairment and depressive-like behaviors


M Malik, C Rangel-Barajas, RH Mach, RR Luedtke 2016 Pharmacol Biochem Behav 218: 138–153 The effect of the sigma-1 receptor selective compound LS-1-137 on the DOI-induced head twitch response in mice

V Sabino, Cottone, SL Parylak, L Steardo, EP Zorrilla 2009 Behav Brain Res 198: 472–476 Sigma-1 receptor knockout mice display a depressive-like phenotype
A Szabo
A Kovacs
J Riba
S Djurovic
E Rajnavolgyi
E Frecska
2016
Frontiers in
Neuroscience
10: 423
1–11
Zoom
May 1
UCL
173
Jason
Gale
A hallucinogenic serotonin-2A receptor agonist reduces visual response gain and alters temporal dynamics in mouse V1

Background papers:

Halberstadt, Chatha, Klein, Wallach, Brandt 2020 Neuropharmacology 167: 107933 1–12 Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species

Riga, Bortolozzi, Campa, Artigas, Celada 2016 Neuropharmacology 101: 370–378 The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT1A and 5-HT2A receptors
AM Michaiel
PRL Parker
CM Niell
2019
Cell
Reports
26:
3475–3483
Zoom
Serotonergic Psychedelics Take Home Messages
Search for papers:

Pub Med

Use these sources to retrieve papers online

Science Direct



Next Semester (Fall 2016): Sleep
Last Semester (Fall 2015): Endocannabinoids